Saquinavir mesylate - Generic Drug Details
✉ Email this page to a colleague
What are the generic sources for saquinavir mesylate and what is the scope of freedom to operate?
Saquinavir mesylate
is the generic ingredient in one branded drug marketed by Hoffmann La Roche and Hoffmann-la Roche, and is included in two NDAs. Additional information is available in the individual branded drug profile pages.There is one drug master file entry for saquinavir mesylate. One supplier is listed for this compound.
Summary for saquinavir mesylate
US Patents: | 0 |
Tradenames: | 1 |
Applicants: | 2 |
NDAs: | 2 |
Drug Master File Entries: | 1 |
Finished Product Suppliers / Packagers: | 1 |
Raw Ingredient (Bulk) Api Vendors: | 68 |
Clinical Trials: | 8 |
Patent Applications: | 6,465 |
Formulation / Manufacturing: | see details |
What excipients (inactive ingredients) are in saquinavir mesylate? | saquinavir mesylate excipients list |
DailyMed Link: | saquinavir mesylate at DailyMed |
Recent Clinical Trials for saquinavir mesylate
Identify potential brand extensions & 505(b)(2) entrants
Sponsor | Phase |
---|---|
National Institute of Allergy and Infectious Diseases (NIAID) | N/A |
AIDS Clinical Trials Group | N/A |
Abbott | Phase 2 |
Pharmacology for saquinavir mesylate
Drug Class | Protease Inhibitor |
Mechanism of Action | Cytochrome P450 3A Inhibitors HIV Protease Inhibitors |
US Patents and Regulatory Information for saquinavir mesylate
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Hoffmann-la Roche | INVIRASE | saquinavir mesylate | TABLET;ORAL | 021785-001 | Dec 17, 2004 | DISCN | Yes | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
Hoffmann La Roche | INVIRASE | saquinavir mesylate | CAPSULE;ORAL | 020628-001 | Dec 6, 1995 | DISCN | Yes | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Expired US Patents for saquinavir mesylate
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
---|---|---|---|---|---|---|---|
Hoffmann La Roche | INVIRASE | saquinavir mesylate | CAPSULE;ORAL | 020628-001 | Dec 6, 1995 | ⤷ Try a Trial | ⤷ Try a Trial |
Hoffmann-la Roche | INVIRASE | saquinavir mesylate | TABLET;ORAL | 021785-001 | Dec 17, 2004 | ⤷ Try a Trial | ⤷ Try a Trial |
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >Patent No. | >Patent Expiration |
Make Better Decisions: Try a trial or see plans & pricing
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.